nach oben

Reactions Weekly

Erschienen in:

01.07.2019 | Case report

Cobicistat/darunavir

GI disturbances and hypersensitivity presenting as urticaria: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

In a multicenter retrospective observational study of 173 adult patients switched to cobicistat/darunavir between November 2015 and June 2017, 2 adult patients [sexes and specific ages not stated] were described, who developed GI disturbances or hypersensitivity presenting as urticaria during treatment with cobicistat/darunavir for HIV-1 infection. …

Santos JR, et al. Simplification of Antiretroviral Treatment from Darunavir/Ritonavir Monotherapy to Darunavir/Cobicistat Monotherapy: Effectiveness and Safety in Routine Clinical Practice. AIDS Research and Human Retroviruses 35: 513-518, No. 6, Jun 2019. Available from: URL: http://doi.org/10.1089/aid.2018.0178 - Spain

Titel: Cobicistat/darunavir
GI disturbances and hypersensitivity presenting as urticaria: 2 case reports
Publikationsdatum: 01.07.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-64487-1

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Cobicistat/darunavir

GI disturbances and hypersensitivity presenting as urticaria: 2 case reports

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

Sildenafil

Cytarabine/fludarabine

Bupivacaine/lidocaine

Lacosamide

Adalimumab/azathioprine

Haemophilus influenza pneumococcal vaccine